Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
Edited Transcript of AVNS earnings conference call or presentation 6-May-20 1:00pm GMT
09:36pm, Saturday, 23'rd May 2020
Q1 2020 Avanos Medical Inc Earnings Call
Here's Why You Should Retain Avanos Medical Stock for Now
11:02am, Monday, 18'th May 2020
Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.
The enteral syringe market size has the potential to grow by USD 196.72 million during 2020-2024
Insights into the Worldwide Enteral Syringe Industry to 2024 - Key Trends, Growth Drivers and Challenges - ResearchAndMarkets.com
12:00am, Wednesday, 13'th May 2020
The
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2020 Results - Earnings Call Transcript
01:04pm, Saturday, 09'th May 2020
Avanos Medical, Inc. (NYSE:AVNS) Q1 2020 Earnings Conference Call May 06, 2020, 09:00 AM ET Company Participants Dave Crawford - Vice President of Investor Rela
Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top
12:59pm, Friday, 08'th May 2020
Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
Avanos Medical, Inc. (AVNS) Q1 2020 Earnings Call Transcript
09:00pm, Wednesday, 06'th May 2020
AVNS earnings call for the period ending March 31, 2020.
Avanos Medical: Q1 Earnings Insights
01:00pm, Wednesday, 06'th May 2020
Shares of Avanos Medical (NYSE:AVNS) were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share rose 6.67% over the past year to $0.16, which were
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
12:55pm, Wednesday, 06'th May 2020
Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. Announces First Quarter 2020 Results and Provides an Update on its Response to the COVID-19 Pandemic
11:00am, Wednesday, 06'th May 2020
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic.
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Avanos Medical Inc (NYSE:AVNS) Short Interest Up 12.0% in April
05:10am, Saturday, 02'nd May 2020
Avanos Medical Inc (NYSE:AVNS) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 2,810,000 shares, an increase of 12.0% from the March
